Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014, Article ID 486403, 9 pages
http://dx.doi.org/10.1155/2014/486403
Review Article

Stress Hyperglycemia, Insulin Treatment, and Innate Immune Cells

1Ross Tilley Burn Centre, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Room D704, Toronto, ON, Canada
2Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada M4N 3M5
3Department of Surgery, Division of Plastic Surgery, Department of Immunology, University of Toronto, Toronto, ON, Canada

Received 28 January 2014; Revised 6 April 2014; Accepted 8 April 2014; Published 8 May 2014

Academic Editor: Kristin Eckardt

Copyright © 2014 Fangming Xiu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. E. Marik and R. Bellomo, “Stress hyperglycemia: an essential survival response!,” Critical Care, vol. 17, no. 2, article 305, 2013. View at Publisher · View at Google Scholar
  2. G. van den Berghe, P. Wouters, F. Weekers et al., “Intensive insulin therapy in critically ill patients,” The New England Journal of Medicine, vol. 345, no. 19, pp. 1359–1367, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. P. E. Marik and M. Raghavan, “Stress-hyperglycemia, insulin and immunomodulation in sepsis,” Intensive Care Medicine, vol. 30, no. 5, pp. 748–756, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. G. A. Mecott, A. M. Al-Mousawi, G. G. Gauglitz, D. N. Herndon, and M. G. Jeschke, “The role of hyperglycemia in burned patients: evidence-based studies,” Shock, vol. 33, no. 1, pp. 5–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. D. Kerby, R. L. Griffin, P. MacLennan, and L. W. Rue III, “Stress-induced hyperglycemia, not diabetic hyperglycemia, is associated with higher mortality in trauma,” Annals of Surgery, vol. 256, no. 3, pp. 446–452, 2012. View at Publisher · View at Google Scholar
  6. X. Zhang, G. Zhang, H. Zhang, M. Karin, H. Bai, and D. Cai, “Hypothalamic IKKβ/NF-κB and ER Stress Link Overnutrition to Energy Imbalance and Obesity,” Cell, vol. 135, no. 1, pp. 61–73, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Xiu and M. G. Jeschke, “Perturbed mononuclear phagocyte system in severely burned and septic patients,” Shock, vol. 40, pp. 81–88, 2013. View at Google Scholar
  8. M. Guha, W. Bai, J. L. Nadler, and R. Natarajan, “Molecular mechanisms of tumor necrosis factor α gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and—independent pathways,” Journal of Biological Chemistry, vol. 275, no. 23, pp. 17728–17739, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Shanmugam, M. A. Reddy, M. Guha, and R. Natarajan, “High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells,” Diabetes, vol. 52, no. 5, pp. 1256–1264, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Shanmugam, I. T. G. Gonzalo, and R. Natarajan, “Molecular mechanisms of high glucose-induced cyclooxygenase-2 expression in monocytes,” Diabetes, vol. 53, no. 3, pp. 795–802, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Devaraj and I. Jialal, “Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathway,” Cytokine, vol. 47, no. 1, pp. 6–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Devaraj, S. K. Venugopal, U. Singh, and I. Jialal, “Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase C-α and -β,” Diabetes, vol. 54, no. 1, pp. 85–91, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Gonzalez, M. T. Herrera, G. Soldevila et al., “High glucose concentrations induce TNF-alpha production through the down-regulation of CD33 in primary human monocytes,” BMC Immunology, vol. 13, article 19, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Leonidou, A. Mouzaki, M. Michalaki et al., “Cytokine production and hospital mortality in patients with sepsis-induced stress hyperglycemia,” Journal of Infection, vol. 55, no. 4, pp. 340–346, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Wei, K. Chen, A. T. Whaley-Connell, C. S. Stump, J. A. Ibdah, and J. R. Sowers, “Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 294, no. 3, pp. R673–R680, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. R. Dasu, S. Devaraj, L. Zhao, D. H. Hwang, and I. Jialal, “High glucose induces toll-like receptor expression in human monocytes Mechanism of activation,” Diabetes, vol. 57, no. 11, pp. 3090–3098, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Haidet, V. Cifarelli, M. Trucco, and P. Luppi, “C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia,” Inflammation Research, vol. 61, no. 1, pp. 27–35, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Qadan, E. B. Weller, S. A. Gardner, C. Maldonado, D. E. Fry, and H. C. Polk Jr., “Glucose and surgical sepsis: a study of underlying immunologic mechanisms,” Journal of the American College of Surgeons, vol. 210, no. 6, pp. 966–974, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Turina, F. N. Miller, C. F. Tucker, and H. C. Polk, “Short-term hyperglycemia in surgical patients and a study of related cellular mechanisms,” Annals of Surgery, vol. 243, no. 6, pp. 845–851, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Nandy, R. Janardhanan, D. Mukhopadhyay, and A. Basu, “Effect of hyperglycemia on human monocyte activation,” Journal of Investigative Medicine, vol. 59, no. 4, pp. 661–667, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. V. J. Liu, A. Saini, D. J. Cohen, and B. S. Ooi, “Modulation of macrophage proliferation by hyperglycemia,” Molecular and Cellular Endocrinology, vol. 114, no. 1-2, pp. 187–192, 1995. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Saini, Y. J. Liu, D. J. Cohen, and B. S. Ooi, “Hyperglycemia augments macrophage growth responses to colony-stimulating factor-1,” Metabolism, vol. 45, no. 9, pp. 1125–1129, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Lamharzi, C. B. Renard, F. Kramer et al., “Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL,” Diabetes, vol. 53, no. 12, pp. 3217–3225, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. C. E. Wade, “Hyperglycemia may alter cytokine production and phagocytosis by means other than hyperosmotic stress,” Critical Care, vol. 12, no. 5, article 182, 2008. View at Google Scholar · View at Scopus
  25. H. Yamasawa, M. Nakayama, M. Bando, and Y. Sugiyama, “Impaired inflammatory responses to multiple Toll-like receptor ligands in alveolar macrophages of streptozotocin-induced diabetic mice,” Inflammation Research, vol. 61, pp. 417–426, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Sun, L. Sun, H. Ma et al., “The phenotype and functional alterations of macrophages in mice with hyperglycemia for long term,” Journal of Cellular Physiology, vol. 227, no. 4, pp. 1670–1679, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. G. A. Kulp, R. G. Tilton, D. N. Herndon, and M. G. Jeschke, “Hyperglycemia exacerbates burn-induced liver inflammation via noncanonical nuclear factor-kappaB pathway activation,” Molecular Medicine, vol. 18, pp. 948–956, 2012. View at Google Scholar
  28. J. C. Alves-Filho, F. Spiller, and F. Q. Cunha, “Neutrophil paralysis in sepsis,” Shock, vol. 34, no. 1, pp. 15–21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Turina, F. N. Miller, C. Tucker, and H. C. Polk Jr., “Effects of hyperglycemia, hyperinsulinemia, and hyperosmolarity on neutrophil apoptosis,” Surgical Infections, vol. 7, no. 2, pp. 111–121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. M. E. Stegenga, S. N. van der Crabben, R. M. E. Blümer et al., “Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia,” Blood, vol. 112, no. 1, pp. 82–89, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. T. C. Alba-Loureiro, S. M. Hirabara, J. R. Mendonç, R. Curi, and T. C. Pithon-Curi, “Diabetes causes marked changes in function and metabolism of rat neutrophils,” Journal of Endocrinology, vol. 188, no. 2, pp. 295–303, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. L. M. McManus, R. C. Bloodworth, T. J. Prihoda, J. L. Blodgett, and R. N. Pinckard, “Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia,” Journal of Leukocyte Biology, vol. 70, no. 3, pp. 395–404, 2001. View at Google Scholar · View at Scopus
  33. B. Toth, M. Alexander, T. Daniel, I. H. Chaudry, W. J. Hubbard, and M. G. Schwacha, “The role of γδ T cells in the regulation of neutrophil-mediated tissue damage after thermal injury,” Journal of Leukocyte Biology, vol. 76, no. 3, pp. 545–552, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Daniel, B. M. Thobe, I. H. Chaudry, M. A. Choudhry, W. J. Hubbard, and M. G. Schwacha, “Regulation of the postburn wound inflammatory response by γδ T-cells,” Shock, vol. 28, no. 3, pp. 278–283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. K. R. Taylor, R. E. Mills, A. E. Costanzo, and J. M. Jameson, “γδ T cells are reduced and rendered unresponsive by hyperglycemia and chronic TNFα in mouse models of obesity and metabolic disease,” PLoS ONE, vol. 5, no. 7, Article ID e11422, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Gyurko, C. C. Siqueira, N. Caldon, L. Gao, A. Kantarci, and T. E. Van Dyke, “Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice,” Journal of Immunology, vol. 177, no. 10, pp. 7250–7256, 2006. View at Google Scholar · View at Scopus
  37. G. De La Rosa, E. M. Vasquez, A. M. Quintero et al., “The potential impact of admission insulin levels on patient outcome in the intensive care unit,” Journal of Trauma and Acute Care Surgery, vol. 74, pp. 270–275, 2013. View at Google Scholar
  38. M. G. Jeschke, “Clinical review: glucose control in severely burned patients—current best practice,” Critical Care, vol. 17, article 232, 2013. View at Google Scholar
  39. H. P. Deng and J. K. Chai, “The effects and mechanisms of insulin on systemic inflammatory response and immune cells in severe trauma, burn injury, and sepsis,” International Immunopharmacology, vol. 9, no. 11, pp. 1251–1259, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Weekers, A. P. Giulietti, M. Michalaki et al., “Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness,” Endocrinology, vol. 144, no. 12, pp. 5329–5338, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. N. A. Hartell, H. E. Archer, and C. J. Bailey, “Insulin-stimulated endothelial nitric oxide release is calcium independent and mediated via protein kinase B,” Biochemical Pharmacology, vol. 69, no. 5, pp. 781–790, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Sarigianni, E. Bekiari, A. Tsapas et al., “Effect of glucose and insulin on oxidized low-density lipoprotein phagocytosis by human monocytes: a pilot study,” Angiology, vol. 62, no. 2, pp. 163–166, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Dimitriadis, E. Maratou, E. Boutati, K. Psarra, C. Papasteriades, and S. A. Raptis, “Evaluation of glucose transport and its regulation by insulin in human monocytes using flow cytometry,” Cytometry Part A, vol. 64, no. 1, pp. 27–33, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Wurm, M. Neumeier, J. Weigert et al., “Insulin induces monocytic CXCL8 secretion by the mitogenic signalling pathway,” Cytokine, vol. 44, no. 1, pp. 185–190, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. R. C. Bunn, G. E. Cockrell, Y. Ou, K. M. Thrailkill, C. K. Lumpkin Jr., and J. L. Fowlkes, “Palmitate and insulin synergistically induce IL-6 expression in human monocytes,” Cardiovascular Diabetology, vol. 9, article 73, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Fortuño, G. San José, M. U. Moreno, O. Beloqui, J. Díez, and G. Zalba, “Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome,” Diabetes, vol. 55, no. 1, pp. 209–215, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. A. J. Gerrits, C. A. Koekman, C. Yildirim, R. Nieuwland, and J. W. N. Akkerman, “Insulin inhibits tissue factor expression in monocytes,” Journal of Thrombosis and Haemostasis, vol. 7, no. 1, pp. 198–205, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Cuschieri, E. Bulger, R. Grinsell, I. Garcia, and R. V. Maier, “Insulin regulates macrophage activation through activin A1,” Shock, vol. 29, no. 2, pp. 285–290, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Yoon, S. Subramanian, Y. Ding et al., “Chronic insulin therapy reduces adipose tissue macrophage content in LDL-receptor-deficient mice,” Diabetologia, vol. 54, no. 5, pp. 1252–1260, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. K. T. Iida, H. Suzuki, H. Sone et al., “Insulin inhibits apoptosis of macrophage cell line, THP-1 cells, via phosphatidylinositol-3-kinase-dependent pathway,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 3, pp. 380–386, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Leffler, T. Hrach, M. Stuerzl, R. E. Horch, D. N. Herndon, and M. G. Jeschke, “Insulin attenuates apoptosis and exerts anti-inflammatory effects in endotoxemic human macrophages,” Journal of Surgical Research, vol. 143, no. 2, pp. 398–406, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. M. Park, S. RK, J. AM, and R. L. Silverstein, “Insulin promotes macrophage foam cell formation: potential implications in diabetes-related atherosclerosis,” Laboratory Investigation, vol. 92, pp. 1171–1180, 2012. View at Publisher · View at Google Scholar
  53. H. Sano, T. Higashi, K. Matsumoto et al., “Insulin enhances macrophage scavenger receptor-mediated endocytic uptake of advanced glycation end products,” Journal of Biological Chemistry, vol. 273, no. 15, pp. 8630–8637, 1998. View at Publisher · View at Google Scholar · View at Scopus
  54. D. G. Ceschin, M. C. Sánchez, and G. A. Chiabrando, “Insulin induces the low density lipoprotein receptor-related protein 1 (LRP1) degradation by the proteasomal system in J774 macrophage-derived cells,” Journal of Cellular Biochemistry, vol. 106, no. 3, pp. 372–380, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Wu, Y. Chen, W. R. Winnall, D. J. Phillips, and M. P. Hedger, “Regulation of activin A release from murine bone marrow-derived neutrophil precursors by tumour necrosis factor-alpha and insulin,” Cytokine, vol. 61, pp. 199–204, 2013. View at Google Scholar
  56. S. Walrand, C. Guillet, Y. Boirie, and M.-P. Vasson, “In vivo evidences that insulin regulates human polymorphonuclear neutrophil functions,” Journal of Leukocyte Biology, vol. 76, no. 6, pp. 1104–1110, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Walrand, C. Guillet, Y. Boirie, and M.-P. Vasson, “Insulin differentially regulates monocyte and polymorphonuclear neutrophil functions in healthy young and elderly humans,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 7, pp. 2738–2748, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. A. J. Rassias, A. L. Givan, C. A. S. Marrin, K. Whalen, J. Pahl, and M. P. Yeager, “Insulin increases neutrophil count and phagocytic capacity after cardiac surgery,” Anesthesia and Analgesia, vol. 94, no. 5, pp. 1113–1119, 2002. View at Google Scholar · View at Scopus
  59. A. M. Laird, P. R. Miller, P. D. Kilgo, J. W. Meredith, and M. C. Chang, “Relationship of early hyperglycemia to mortality in trauma patients,” The Journal of Trauma, vol. 56, no. 5, pp. 1058–1062, 2004. View at Google Scholar · View at Scopus
  60. D. Tuvdendorj, X. J. Zhang, D. L. Chinkes et al., “Intensive insulin treatment increases donor site wound protein synthesis in burn patients,” Surgery, vol. 149, no. 4, pp. 512–518, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. T. N. Pham, A. J. Warren, H. H. Phan, F. Molitor, D. G. Greenhalgh, and T. L. Palmieri, “Impact of tight glycemic control in severely burned children,” Journal of Trauma, vol. 59, no. 5, pp. 1148–1154, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. C. V. Murphy, R. Coffey, C. H. Cook, A. T. Gerlach, and S. F. Miller, “Early glycemic control in critically Ill patients with burn injury,” Journal of Burn Care and Research, vol. 32, no. 6, pp. 583–590, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. P. Vespa, R. Boonyaputthikul, D. L. McArthur et al., “Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury,” Critical Care Medicine, vol. 34, no. 3, pp. 850–856, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. J. A. Frontera, “Intensive versus conventional insulin therapy in critically ill neurologic patients: still searching for the sweet spot,” Neurocritical Care, vol. 13, no. 3, pp. 295–298, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Eakins, “Blood glucose control in the trauma patient,” Journal of diabetes science and technology, vol. 3, no. 6, pp. 1373–1376, 2009. View at Google Scholar · View at Scopus
  66. M. E. Kutcher, M. B. Pepper, D. Morabito, D. Sunjaya, M. M. Knudson, and M. J. Cohen, “Finding the sweet spot: identification of optimal glucose levels in critically injured patients,” Journal of Trauma, vol. 71, no. 5, pp. 1108–1114, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. D. C. Gore, S. E. Wolf, A. Sanford, D. N. Herndon, and R. R. Wolfe, “Influence of metformin on glucose intolerance and muscle catabolism following severe burn injury,” Annals of Surgery, vol. 241, no. 2, pp. 334–342, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. M. G. Cree, J. J. Zwetsloot, D. N. Herndon et al., “Insulin sensitivity and mitochondrial function are improved in children with burn injury during a randomized controlled trial of fenofibrate,” Annals of Surgery, vol. 245, no. 2, pp. 214–221, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. I. E. Elijah, E. Børsheim, D. M. Maybauer, C. C. Finnerty, D. N. Herndon, and M. O. Maybauer, “Role of the PPAR-α agonist fenofibrate in severe pediatric burn,” Burns, vol. 38, no. 4, pp. 481–486, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Seok, H. S. Warren, A. G. Cuenca et al., “Genomic responses in mouse models poorly mimic human inflammatory diseases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 9, pp. 3507–3512, 2013. View at Publisher · View at Google Scholar